Fig. 1From: Follow-up for 3 years of a pediatric population diagnosed in 2018 with mother-to-child transmission of HIV in 8 Latin American countries in the PLANTAIDS cohortART regimens in force at each of the check-upsLegend: Other ART regimens*: ABC (abacavir)-3TC (lamivudine)-DTG (dolutegravir), ABC-3TC-RTV (ritonavir), AZT (zidovudine)-ABC-3TC, ABC-3TC-NVP (nevirapine), AZT-3TC-RTV, 3TC-TDF (tenofovir disoproxil fumarate)-EFV (efavirenz), 3TC-TDF-DTG, AZT-ABC-EFV, AZT-FTC (emtricitabine)-DTG, BIC (bictegravir)-TAF (tenofovir alafenamide)-FTC, AZT-3TC-DTG.Check-up 1: diagnosis - 6 mCheck-up 2: 7 m - 12 mCheck-up 3: 13 m - 24 mCheck-up 4: 25 m - 36 mBack to article page